CA Patent

CA2675836A1 — Composition for preventing or treating thrombus- or embolus-associated disease

Assigned to Mochida Pharmaceutical Co Ltd · Expires 2008-07-24 · 18y expired

What this patent protects

Disclosed is a composition for the prevention or treatment of a disease a ssociated with thrombus or embolus, which comprises a combination of at leas t one member selected from the group consisting of clopidogrel and a pharmac eutically acceptable salt thereof and at least one m…

USPTO Abstract

Disclosed is a composition for the prevention or treatment of a disease a ssociated with thrombus or embolus, which comprises a combination of at leas t one member selected from the group consisting of clopidogrel and a pharmac eutically acceptable salt thereof and at least one member selected from the group consisting of eicosapentaenoic acid and a pharmaceutically salt or est er thereof as active ingredients.

Drugs covered by this patent

Patent Metadata

Patent number
CA2675836A1
Jurisdiction
CA
Classification
—
Expires
2008-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Mochida Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.